Loraine and Natalie Brogan share their type 1 diabetes story and what research and the Participant Advisory Council mean to ...
A decade ago, when I served on the Breakthrough T1D International Board of Directors, I grumbled that most of the pioneering research we funded was revealed at the annual American Diabetes Association ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to four outstanding leaders in T1D research whose impact has pushed Breakthrough ...
New York, Oct. 27, 2026—Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces Dr. Carla Greenbaum as recipient of the 2026 George Eisenbarth ...
New York, Oct. 27, 2026—Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces William Tamborlane, M.D., Ph.D. as the recipient of the 2026 ...
New York, Oct. 27, 2026—Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces Dr. Roy Beck as the recipient of the 2026 Mary Tyler Moore and ...
New York, Oct. 27, 2026—Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces Peter Thompson, Ph.D. as the recipient of the 2026 Dr. Robert ...
Pat McAleer raises his fist in celebration after reaching the Atlantic Ocean at Virginia Beach, VA. On July 15, Pat McAleer flew from Richmond, VA, to Seattle, WA, dipped his bike in the Pacific Ocean ...
A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.
“Unannounced Meals” Functionality Would Provide Significant Quality-of-Life Improvements for People Living with Type 1 Diabetes PALO ALTO, Calif., Oct. 22, 2026—Tidepool, a non-profit leader advancing ...
A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...